(Reuters) - U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious virus in its phase 2a study among participants with early COVID-19. "The secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising," said William Fischer, Associate Professor of Medicine at the University of North Carolina School of Medicine, in a statement from the companies. The antiviral is being currently t...
Enjoy good journalism?
… then let us make a small request. The COVID crisis has slashed advertising rates, and we need your help. Like you, we here at Raw Story believe in the power of progressive journalism. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and legal efforts to harm workers exploited by abusive bosses. And unlike other news outlets, we’ve decided to make our original content free. But we need your support to do what we do.
Raw Story is independent. Unhinged from corporate overlords, we fight to ensure no one is forgotten.
We need your support in this difficult time. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you. Click to donate by check.
Value Raw Story?
… then let us make a small request. The COVID crisis has slashed advertising rates, and we need your help. Like you, we believe in the power of progressive journalism — and we’re investing in investigative reporting as other publications give it the ax. Raw Story readers power David Cay Johnston’s DCReport, which we've expanded to keep watch in Washington. We’ve exposed billionaire tax evasion and uncovered White House efforts to poison our water. We’ve revealed financial scams that prey on veterans, and efforts to harm workers exploited by abusive bosses. We need your support to do what we do.
Raw Story is independent. You won’t find mainstream media bias here. Every reader contribution, whatever the amount, makes a tremendous difference. Invest with us in the future. Make a one-time contribution to Raw Story Investigates, or click here to become a subscriber. Thank you.
Donald Trump cost Republicans the White House and their majorities in the Senate and House in the last five years, but the GOP still sees the 74-year-old ex-president as the future of the party.
The twice-impeached one-term president is the favorite for the 2024 nomination should he choose to run, and conservative Matt Lewis lamented in a new Daily Beast column that Republicans are jetting off to Mar-A-Lago for fundraisers and racing to out-Trump one another in their own campaigns.
"After a drubbing in November followed by a violent and violently stupid insurrection attempt in January, they are doubling down on a proven loser," Lewis wrote. "It's just weird to have the guy who just LOST the presidency remain the party's undisputed leader. In our lifetime, one-term presidents (not to mention losing nominees) have been pushed out the door faster than Milli Vanilli. In 1981, nobody was clamoring for more Jimmy Carter. But Republicans just can't quit the former president — no matter how much grief he has caused them (and the nation)."
"To paraphrase Homer Simpson's toast to alcohol," he added, "they see Donald Trump as the cause of, and the solution to, all of the party's problems."
Lewis pointed to Ohio's crowded GOP Senate race, where early frontrunners J.D. Vance and Josh Mandel are dialing up the bigotry and culture war trolling to win over Trump voters.
"Whether it's Republicans schlepping to Florida to bend the knee, likely 2024 presidential candidates deferring to him, or a new crop of U.S. Senate candidates falling all over themselves (and, in one case, being escorted out of a hotel) for the chance to touch the hem of his garment, you have to ask yourself why, since nothing good comes for anyone else from getting anywhere near him," Lewis wrote.
Rival vaccine makers declined request from Johnson & Johnson for help with blood clotting issues: report
According to an exclusive report from the Wall Street Journal, Johnson & Johnson requested help from rival COVID-19 vaccine manufacturers Pfizer and Moderna with help investigating blood clotting issues with their offering intended to curb the pandemic and were turned down.
Earlier in the week, the CDC issued a warning about the Johnson & Johnson vaccine and urged a pause after a reported six patients -- all women -- developed blood clotting problems.
Friday morning, the Wall Street Journal claimed J&J reached out to their competitors and were rebuffed with the exception of AstraZeneca.
"Johnson & Johnson privately reached out to Covid-19 vaccine rivals to ask them to join an effort to study the risks of blood clots and speak with one voice about safety, " the report states before adding, "Pfizer and Moderna executives declined the offer, saying their vaccines appeared safe, the people said. The pair also objected because they didn't see the need to duplicate the efforts of regulators and companies already looking for blood-clot cases and investigating the cause, the people said. One company's concern: The safety of the Pfizer and Moderna shots could be tarnished by association, some of the people said."
The report adds, "Only AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, the people said."
You can read more here -- subscription required.
A gym in Quebec City that has defied lockdown orders during the COVID-19 pandemic has now been linked to hundreds of cases, including one death.
The CBC reports that the Canadian health officials believe the Mega Fitness Gym 24H in Quebec City served as a super-spreader center for the novel coronavirus in the weeks before it was officially shut down for defying pandemic restrictions.
"To date, there have been 224 people infected at the gym, and another 356 related cases involving outbreaks at 49 workplaces," reports the CBC. "A 40-year-old man who trained at the gym has died."
The gym's owner, a man named Dan Marino, has grown notorious in recent months for attacking pandemic restrictions, and has even written social media posts questioning the effectiveness of masks and downplaying the severity of the pandemic.
Before it was shut down, Marino's gym was in violation of multiple health orders, including mandating that patrons maintain social distance and requiring employees to wear protective gear.
Raymond Tellier, an infectious diseases specialist, medical microbiologist and associate medical professor at McGill University, tells CBC that the mass outbreak from one single gym was nothing less than "stunning."
"This is the kind of setting where if you don't have proper ventilation and if you have too much crowding, you could indeed have a superspreading event linked to aerosol," he said. "This one is remarkable."
Don't Sit on the Sidelines of History. Join Raw Story Investigates and Go Ad-Free. Support Honest Journalism.
$95 / year — Just $7.91/month
I want to Support More
$14.99 per month